Concept: Tyrosine-kinase inhibitor

A Case Report of Promising Response to Combination Therapy With an Immune Checkpoint Inhibitor (Pembrolizumab) and Multi‐Targeted Tyrosine Kinase Inhibitor (Pazopanib) in Metastatic De‐Differentiated Chondrosarcoma

Dual immunotherapy and kinase inhibitor combination shows promise in advanced chondrosarcoma